Efficacy and Safety of Combination Therapy of Vildagliptin/Metformin in Patients in Type 2 Diabetes Mellitus (T2DM)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 161 participants.
Also called NCT01196546
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 161 participants
- Sponsor
- Registry
-
NCT01196546
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Thailand
- Registry status
- Completed
Technical summary
Registry record NCT01196546. Allocation not applicable; no masking; primary purpose treatment. Start 2010-03 (registry gives no type); primary completion 2011-10 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of Combination Therapy of Vildagliptin/Metformin in Patients in Type 2 Diabetes Mellitus (T2DM)
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- vildagliptin/metformin
- Lead sponsor
- Novartis
Record details
- Record id
cardio:ct-nct01196546- Content hash
e6957fa0f1d735f5903739a1d4734727df3a72ff8f9f0cc586c17198b9deb0d3